ROSEMARY CASTILLO: Open Payments
NPI 1891854519 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 8 payments from 6 companies in 2025. Trend: 2023 $974 · 2024 $1,018 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $238 |
| Edwards Lifesciences Corporation | 1 | $197 |
| Abbott Laboratories | 2 | $193 |
| Madrigal Pharmaceuticals | 1 | $145 |
| ABBVIE INC. | 1 | $122 |
| GENZYME CORPORATION | 1 | $111 |
Products named: SAPIEN 3 Ultra RESILIA, REZDIFFRA, UZEDY, ALINITY, QULIPTA, AUSTEDO XR, INFINITY.
Industry payments across CA — which companies pay providers there.
